Transaktionen anzeigen
Gesundheitswesen | TMT | Private Equity

Improve International Ltd. has been acquired by RJD Partners

Benchmark Holdings Plc. has sold Improve International Ltd. to RJD Partners.

Improve International provides both specialist postgraduate courses and qualifications as well as continuing professional development training to veterinary professionals. Its key programs are structured on a modular basis comprising both face-to-face practical and classroom learning as well as online delivery. With offices in the UK and Portugal, the business has global operations across the US, Australia and Japan. Courses are also available in multiple languages.

Founded in 2000, RJD Parters is an equity investor specializing in buy-outs, buy-ins and development capital for deals worth up to US$60 million.

Benchmark Holdings develops products and solutions in genetics, health and nutrition that improve performance, animal health and welfare, and reduce environmental impact across the aquaculture production cycle.

Oaklins Cavendish, based in the UK, advised the seller on this transaction.

DIENSTLEISTUNG
PARTEIEN
«I would thoroughly recommend the Oaklins Cavendish team to anyone looking to maximize the proceeds from a disposal or asset sale. The team are both consummate professionals, focused on delivery and pragmatic and flexible in their approach to helping their clients achieve their objectives. I would not hesitate to recommend them and would hope to work with them on future projects. They provide great value.»

James Banfield

Head of Knowledge Services, Benchmark Holdings Plc.

Sprechen Sie mit dem Deal Team

Andrew Jeffs

Partner
London, Grossbritannien
Oaklins Cavendish

Rebecca McCredie

Director
London, Grossbritannien
Oaklins Cavendish

Transaktionen

Valmiermuižas Alus has been acquired by Cēsu Alus
Private Equity | Lebensmittel- und Getränkeindustrie

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

Mehr erfahren
Die Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland
Gesundheitswesen

Die Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland

Die LabPoint Medizinische Laboratorien AG wurde von Affidea Switzerland AG übernommen. Mit Affidea hat die Lindenhofgruppe AG einen starken strategischen Partner für die Weiterentwicklung der LabPoint gewonnen. Die Lindenhofgruppe bleibt bedeutende Aktionärin und Grosskundin des Unternehmens. Damit schafft sie die Grundlage für eine nachhaltige Weiterentwicklung von LabPoint unter einer neuen Ankeraktionärin. LabPoint soll ihre Position in der Labordiagnostik weiter stärken und gezielt ausbauen.

Mehr erfahren
Armira has signed an agreement to acquire a majority stake in Viabus
Private Equity | Handel

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

Mehr erfahren